13 October 2025

New AI-platform to strengthen global pandemic preparedness

AI

Samir Bhatt, Professor at the Department of Public Health, is joining the establishment of a new center aimed at developing an AI-powered platform to enhance global pandemic preparedness.

The Global Pathogen Analysis Platform (GPAP) will improve international surveillance of infectious diseases.

It is a privilege to be involved in developing this initiative. Our proposed platform represents a major step toward stronger global pandemic preparedness in a time where this is needed more than ever.

Samir Bhatt

Based at DTU and developed in collaboration with researchers from the University of Copenhagen, Statens Serum Institut, and Imperial College London—with support from the Novo Nordisk Foundation—the platform will provide free access to advanced AI tools for pathogen analysis. The goal is to close gaps in global preparedness and enable faster detection and response to future outbreaks.

At the University of Copenhagen, the funding will, among other things, be used to develop new AI methods for analyzing metagenomics

GPAP: Stopping health threats before they become global

Infectious diseases spread between humans, animals, and the environment. GPAP is therefore built on the One Health principle, recognizing the close connection between human, animal, and environmental health. The platform integrates genetic data on pathogens with other data sources—such as climate, mobility, and trade—within a secure online infrastructure. This cross-sectoral data sharing enables faster and more effective responses to emerging health threats.

AI-tools to make pandemic response more accessible

WHO’s pandemic agreement from May 2025 highlights the urgent need for global data sharing and equitable access to technology. GPAP addresses this by offering integrated, pre-trained AI tools that simplify complex analyses—even in resource-

By strengthening global pathogen surveillance and research we hope to save millions of lives and prevent pandemics in the future.

With the help of the Novo Nordisk Foundation Denmark will continue to play a central part in the global fight against infectious diseases.

Henrik Wegener

limited settings. Users can interpret genetic data, generate automated summaries, and retain full control over their data.

To ensure GPAP meets user needs, the platform will be developed in close collaboration with stakeholders in low- and middle-income countries. This will take place at so-called “activator sites,” where GPAP is tested and refined with input from local researchers, health authorities, and other potential users.

The establishment and development of GPAP is led by Professor Henrik C. Wegener, former Rector of the University of Copenhagen. The Novo Nordisk Foundation is supporting the initiative with up to DKK 200 million over six years. A long-term funding plan for the platform will also be developed as part of the project.


More about the Global Pathogen Analysis Platform (GPAP)

GPAP will be headquartered at DTU’s National Food Institute, with partner institutions including the University of Copenhagen, Statens Serum Institut, and Imperial College London, as well as international collaborators in Europe, Africa, and Asia.

GPAP will be developed in accordance with international and national regulations in public health, animal health, and environmental health, and guided by ethical principles such as the FAIR and CARE data standards.


Read more: New platform to strengthen our global defence against future pandemics - Novo Nordisk Fonden

Contact

Professor Samir Bhatt
IFSV
samir.bhatt@sund.ku.dk

Topics